These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 369867)

  • 1. Serological evidence for antigenic differences between the Mason-Pfizer monkey virus (MPMV) and an MPMV-like virus (PMFV) detected in a malignant permanent human cell line.
    Micheel B; Baumbach L; Wunderlich V; Niezabitowski A; Bierwolf D
    Eur J Cancer (1965); 1979 Jan; 15(1):101-8. PubMed ID: 369867
    [No Abstract]   [Full Text] [Related]  

  • 2. Common antigenic determinants on structural proteins p10--12 of PMFV and MPMV type D retroviruses.
    Voevodin AF; Wunderlich V; Denner J; Bierwolf D; Lapin BA
    Neoplasma; 1980; 27(3):225-8. PubMed ID: 6161313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and immunological characterization of structural proteins from retrovirus-D/New England and comparison to Mason-Pfizer monkey virus and permanent human fibroblast virus.
    Uckert W; Wunderlich V; Fiebach H; Hertling I; Stein U; Kraft R; Desrosiers R
    Arch Virol; 1987; 94(3-4):267-82. PubMed ID: 3579611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Sepharose bead immunofluorescence assay for comparison of the type D retroviruses MPMV and PMFV.
    Micheel B; Uckert W; Denner J; Fiebach H; Wunderlich V
    Arch Geschwulstforsch; 1982; 52(4):275-82. PubMed ID: 6182856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of human lymphocyte mitogen response by retroviruses of type D. II. Non-activity of Mason-Pfizer monkey virus versus activity of human cell line derived virus PMFV.
    Denner J; Indzhiia L; Wunderlich V; Sydow G; Bierwolf D; Lapin BA
    Arch Virol; 1985; 86(3-4):187-96. PubMed ID: 4062558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic analysis of the major structural protein of the Mason-Pfizer monkey virus.
    Schochetman G; Boehm-Truitt M; Schlom J
    J Immunol; 1976 Jul; 117(1):168-73. PubMed ID: 819581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of antigenic cross-reactivity between simian sarcoma virus (SSV) and mason-pfizer monkey virus (MPMV): brief report.
    Micheel B
    Arch Virol; 1981; 69(2):149-53. PubMed ID: 6171238
    [No Abstract]   [Full Text] [Related]  

  • 8. The localization of a Mason-Pfizer monkey virus-related antigen in jaagsiekte tumour tissue and cell lines.
    Payne AL; Verwoerd DW; Garnett HM
    Onderstepoort J Vet Res; 1986 Jun; 53(2):87-91. PubMed ID: 3523361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major structural polypeptides of retrovirus produced by a Suncus murinus mammary tumor cell line and type D retrovirus share interspecies antigenic determinants.
    Aoyama A; Saga S; Nagayoshi S; Yokoi T; Malavasi J; Takenaka T; Tsutsui Y; Hoshino M
    Virology; 1988 Nov; 167(1):314-7. PubMed ID: 2460996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primate retroviruses: immunological cross-reactivity between major structural proteins of new and old world primate virus isolates.
    Devare SG; Arthur LO; Fine DL; Stephenson JR
    J Virol; 1978 Mar; 25(3):797-805. PubMed ID: 76686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protein pattern of PMF virus, a type-D retrovirus from malignant permanent human cell lines.
    Uckert W; Wunderlich V; Bender E; Sydow G; Bierwolf D
    Arch Virol; 1980; 64(2):155-66. PubMed ID: 7387404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of a normal human cell surface antigen with primate retrovirus glycoproteins.
    Sparrow RL; Purcell DF; McKenzie IF
    Hum Immunol; 1985 Jun; 13(2):83-93. PubMed ID: 3924865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibodies reactive with non-human primate retroviruses identified in acute onset schizophrenia.
    Lillehoj EP; Ford GM; Bachmann S; Schröder J; Torrey EF; Yolken RH
    J Neurovirol; 2000 Dec; 6(6):492-7. PubMed ID: 11175321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type D primate retroviruses: a review.
    Fine D; Schochetman G
    Cancer Res; 1978 Oct; 38(10):3123-39. PubMed ID: 80259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological cross reactivity of Mason-Pfizer monkey virus with type C RNA viruses endogenous to primates.
    Stephenson JR; Hino S; Garrett EW; Aaronson SA
    Nature; 1976 Jun; 261(5561):609-11. PubMed ID: 180419
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-reaction between antigens of human myelogenous leukemia and Mason-Pfizer monkey virus.
    Kim BS
    Eur J Cancer (1965); 1977 Jul; 13(7):721-8. PubMed ID: 271610
    [No Abstract]   [Full Text] [Related]  

  • 17. RELATIONSHIP BETWEEN THE Mason-Pfizer monkey virus and Hela virus: immunoelectron microscopy.
    Gelderblom H; Schwarz H
    J Natl Cancer Inst; 1976 Mar; 56(3):635-7. PubMed ID: 56448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human non-lineage antigen CD46 (HuLy-m5) and primate retroviral gp70 molecules share protein-defined antigenic determinants.
    Purcell DF; Deacon NJ; McKenzie IF
    Immunol Cell Biol; 1989 Oct; 67 ( Pt 5)():279-89. PubMed ID: 2482250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological analysis of an oncornavirus (PMF virus) detected in malignant permanent human cell lines.
    Micheel B; Papsdorf G; Wunderlich V; Niezabitowski A; Widmaier R; Bender E; Graffi A
    Acta Biol Med Ger; 1975; 34(4):K 39-45. PubMed ID: 171892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodeficiency in rhesus monkeys associated with the original Mason-Pfizer monkey virus.
    Bryant ML; Gardner MB; Marx PA; Maul DH; Lerche NW; Osborn KG; Lowenstine LJ; Bodgen A; Arthur LO; Hunter E
    J Natl Cancer Inst; 1986 Oct; 77(4):957-65. PubMed ID: 3020302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.